positive controls.
Because of a limited number of available slides, we analyzed PDGFRα in 19 dermatofibroma cases and nestin in 19 dermatofibroma cases. We analyzed fibronectin in 28 DFSP cases, 17 dermatofibroma cases, and 2 MFH cases.
RNA extraction and Reverse Transcription-Polymerase Chain Reaction (RT-PCR):
DFSP tissues, when available, were snap-frozen in liquid nitrogen and stored at 80°C until used.
RNAs were extracted from frozen tumor tissues using the RNeasy Mini kit (QIAGEN, Hilden, Germany) and reverse-transcribed using the superscript VILO cDNA synthesis kit (Invitrogen, Carlsbad, CA, USA).
To detect the presence of COL1A1-PDGFB fusion transcripts, RT-PCR was carried out using one of the COL1A1 forward primers and one PDGFB reverse primer as indicated below. COL1A1 forward primers were designed in exons 5, 8, 11, 15, 17, 20, 23, 26, 29, 32, 35, 38, 40, 43, 46, and 49, and one PDGFB reverse primer was designed in exon 2.
1 In addition, COL1A1 exon 1 forward primer, nine COL1A2 forward primers in exons 1, 5, 11, 17, 23, 29, 35, 40, and 46, COL3A1, COL5A1, COL5A2, COL5A3, elastin, lamininß1, fibronectin1, fibrillin1, fibrillin2, fibulin5 and tenascin XB were prepared (eTable4). cDNA was amplified under stringent conditions with 45 cycles of denaturation at 98°C (10 s), annealing at 66°C (45 s), and elongation at 72°C (2 min). PCR products were electrophoresed on a 1.5% agarose gel and purified using QIAquick Gel Extraction Kit (QIAGEN).
Gene sequences were verified using the Big Dye Terminator Ver. 3.1 Kit, and DNA sequence analysis was performed using BLAST. 
